This aspirin-sized implant could serve as a "hub" to recruit and train immune cells to fight cancer from within the patient's body.

This time, they will be testing an advanced implantable drug delivery device that can be remotely operated, which allows for the controlled distribution of a drug inside the body on demand.

Novartis' Alcon unit boasts the second-largest eyecare business with net sales of $10.5 billion in 2013, and Google is making headway with miniature, wearable devices that provide innovative ...

Novartis AG <NOVN.VX> holds a 10 percent stake in privately owned Swiss dental implant maker Thommen Medical, Thommen said on Monday.

Novartis' logo is seen at the cell and gene therapy factory of the Swiss drugmaker in Stein, Switzerland, November 28, 2019. REUTERS/Arnd Wiegmann Purchase Licensing Rights, opens new tab ...